Profil
Boris Fain is the founder of two companies.
He founded Diagnose Early, Inc. and InterX, Inc. At Diagnose Early, Inc., he held no specific title.
At InterX, Inc., he held the titles of Chief Science Officer and Chief Technology Officer, but is no longer active in those roles.
Aktive Positionen von Boris Fain
Unternehmen | Position | Beginn |
---|---|---|
InterX, Inc.
InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Gründer | - |
Ehemalige bekannte Positionen von Boris Fain
Unternehmen | Position | Ende |
---|---|---|
Diagnose Early, Inc.
Diagnose Early, Inc. Pharmaceuticals: MajorHealth Technology Diagnose Early, Inc. is a company that specializes in non-invasive breath and biometric testing. The company is based in Newark, CA. The company has developed a proprietary breath analysis technology and an AI health data platform that allows users to collect their health data in one place. The company's breath testing technology is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat in minutes. Diagnose Early was founded by Boris Fain, Chris Wheeler, and John Cunniff. Chris Wheeler has been the CEO since incorporation. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
InterX, Inc.
InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Health Technology |
Diagnose Early, Inc.
Diagnose Early, Inc. Pharmaceuticals: MajorHealth Technology Diagnose Early, Inc. is a company that specializes in non-invasive breath and biometric testing. The company is based in Newark, CA. The company has developed a proprietary breath analysis technology and an AI health data platform that allows users to collect their health data in one place. The company's breath testing technology is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat in minutes. Diagnose Early was founded by Boris Fain, Chris Wheeler, and John Cunniff. Chris Wheeler has been the CEO since incorporation. | Health Technology |